Director, Global Strategic Marketing, Lung Cancer

Johnson & Johnson Innovative Medicine is recruiting for a second Director, Global Strategic Marketing, Lung Cancer, located in Raritan, NJ.

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://www.jnj.com/

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day.

Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world.

Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges.

We know that the success of our business - and our ability to deliver meaningful solutions - depends on how well we understand and meet the diverse needs of the communities we serve.

Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson & Johnson, we all belong.

The Director, Global Strategic Marketing, Lung Cancer reports to the Sr.

Director, Global Commercial Strategy, Lung Cancer.

The Director is responsible for owning & leading the commercial strategy, launch excellence, market shaping & development, customer solutions, go-to-market model, and LCM efforts for Rybrevant and Lazcluze (amivantamab and lazertinib).

The role will contribute to optimizing the value of our global J&J Lung Cancer portfolio, by collaborating with key functions across the Global Commercial Strategy Organization (GCSO), J&J Research and Development (R&D), and J&J business regions.

Key responsibilities include, but are not limited to:


* Lead commercial strategy, launch excellence, market shaping & development, go-to-market model, and LCM efforts for Rybrevant and Lazcluze (amivantamab and lazertinib).


* Develop and deliver global marketing campaigns and associated deliverables, with cross-regional and cross-functional buy-in.


* Coordinate with business partners to ensure strategic alignment and execution.


* Establish and deliver unique solutions to elevate the customer experience.


* Partner with Regions to develop, shape and implement commercial strategies, tactics, customer solutions and messaging.


* Work closely with Medical Affairs to ensure robust publication plans and enduring/differentiating data generation and messaging.


* Collaborate with Market Access to develop value propositions that support/bolster reimbursement and approvals globally.


* Partner acros...